Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08BBU
|
|||
| Drug Name |
GW-42003
|
|||
| Indication | Opioid dependence [ICD-11: 6C43.2Z] | Phase 2 | [1] | |
| Company |
GW PharmaceuticalCambridge, United Kingdom Ichan School of MedicineNew York, NY
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.